Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinomaYuki Nemoto, Tsunenori Kondo, Takanori Endo et al.|Research Square|2024Cited by 0
Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinomaYuki Nemoto, Kazutaka Nakamura, Koichi Nishimura et al.|International Urology and Nephrology|2025Cited by 0